Project Grant RC2DK140838
Award Date
9/1/24
Completion Date
7/31/29
Dollars Obligated
$2.8M
Federal Grant Program
93.847
Assistance Type
Project Grant
Place of Performance
Tucson, AZ 85719, USA
Similar Awards
This federal Project Grant award, identified as R01DK141129, was provided by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The $575,394 grant supports research to investigate the role of A-kinase anchoring proteins (AKAPs) and mutant forms of the catalytic subunit of protein kinase A (PKAC) in driving adrenal Cushing's syndrome, an endocrine disorder characterized by...
This federal Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under CFDA 93.847 - Diabetes, Digestive, and Kidney Diseases Extramural Research will provide $632,540.00 to the University of Arkansas for Medical Sciences (UAMS) between September 18, 2024 and May 31, 2029. The funding will support research to investigate the molecular mechanisms that regulate cell fate plasticity in the pituitary gland, with a focus on the role of the mRNA...
This $553,545 Project Grant was awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The grant supports research to elucidate the mechanisms by which methylation of the GNAS gene regulates allelic expression of the Gsα protein and hormone signaling in specific tissues. The research will employ human embryonic stem cell and induced pluripotent stem cell models to...
This Project Grant award from the National Cancer Institute (CFDA 93.394 - Cancer Detection and Diagnosis Research) provides $235,707 to Weill Medical College of Cornell University to characterize the utility of [68Ga]-DOTATATE PET/MRI in pituitary neuroendocrine tumors (PitNET). The key objectives are to: Determine the range of DOTATATE PET standardized uptake values (SUVs) in PitNET and explore associations with clinical, demographic, and endocrine variables. Compare PET/MRI-guided vs....
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded The Trustees of the University of Pennsylvania a $700,619 Project Grant under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The goal of this 4-year research project, awarded on August 19, 2024, is to study and control rhythmic nephron induction for kidney replacement tissues using human induced pluripotent stem cells (iPSCs). The research aims to determine the...
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $647,486 Project Grant under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to Inlighta Biosciences L.L.C., a woman-owned small business in Marietta, Georgia. The goal of this Phase I research is to acquire proof-of-concept results for designing and generating analogs of a calcium-sensing receptor (CaSR) targeted drug candidate, TNCA, that have optimal drug activity...
The Duke University Office of Research Administration has been awarded a $1,287,768 Cooperative Agreement from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The award will establish the Gut Brain Parkinson's Disease Consortium (GBPDC) Coordinating and Data Management Center (CDMC) to address the resource sharing, data science, and analytical challenges unique to this...
This $747,500 federal Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), provided under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), supports research to investigate the potential existence of memory formation in the enteric nervous system (ENS) of the gastrointestinal tract. The goal is to build the tools required for studying the formation and function of ENS memories, and then utilize these tools in...
The University of Pittsburgh received a $198,750 Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (CFDA 93.847) to develop a rapid, quantitative platform using yeast to classify how approximately 70 identified mutations in the polycystin-1 (PC1) protein disrupt channel activity with PC2. This research aims to provide new reagents and assays to the scientific and PKD (polycystic kidney disease) community to study the molecular defects of PC1 mutants. The...
This Cooperative Agreement award of $301,030.00 was provided by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The purpose of the "Pittsburgh Center for Training in Kidney, Urology and Hematology" (PCT-KUH) program is to develop the next generation of kidney, urology and hematology researchers by providing predoctoral students, physicians and PhDs with in-depth...